Zurcher Kantonalbank (Zurich Cantonalbank) Blueprint Medicines Corp Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 13,613 shares of BPMC stock, worth $1.23 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,613

Previous 13,613 -0.0%

Holding current value

$1.23 Million

Previous $1.26 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$84.1 - $120.5 $15,053 - $21,569	-179 Reduced 1.3%	13,613 $1.26 Million
Q2 2024 Jul 29, 2024	BUY	$85.18 - $108.78 $90,631 - $115,741	1,064 Added 8.36%	13,792 $1.49 Million
Q1 2024 Apr 25, 2024	SELL	$73.17 - $99.79 $46,901 - $63,965	-641 Reduced 4.79%	12,728 $1.21 Million
Q4 2023 Jan 30, 2024	BUY	$43.96 - $92.84 $57,763 - $121,991	1,314 Added 10.9%	13,369 $1.23 Million
Q3 2023 Oct 25, 2023	BUY	$46.9 - $66.0 $49,338 - $69,432	1,052 Added 9.56%	12,055 $605,000
Q2 2023 Aug 07, 2023	BUY	$42.2 - $66.37 $59,966 - $94,311	1,421 Added 14.83%	11,003 $695,000
Q1 2023 May 08, 2023	SELL	$37.97 - $50.0 $7,518 - $9,900	-198 Reduced 2.02%	9,582 $431,000
Q4 2022 Feb 01, 2023	BUY	$41.06 - $66.48 $87,498 - $141,668	2,131 Added 27.86%	9,780 $428,000
Q2 2022 Aug 09, 2022	SELL	$45.23 - $70.15 $11,488 - $17,818	-254 Reduced 3.21%	7,649 $386,000
Q1 2022 Apr 21, 2022	SELL	$54.1 - $110.08 $59,888 - $121,858	-1,107 Reduced 12.29%	7,903 $505,000
Q4 2021 Feb 01, 2022	BUY	$94.25 - $115.99 $241,374 - $297,050	2,561 Added 39.71%	9,010 $965,000
Q3 2021 Nov 15, 2021	SELL	$80.98 - $109.47 $161 - $218	-2 Reduced 0.03%	6,449 $663,000
Q2 2021 Jul 30, 2021	BUY	$82.78 - $101.0 $1,738 - $2,121	21 Added 0.33%	6,451 $567,000
Q1 2021 May 03, 2021	SELL	$90.71 - $108.28 $39,005 - $46,560	-430 Reduced 6.27%	6,430 $625,000
Q4 2020 Jan 28, 2021	BUY	$92.08 - $124.48 $117,494 - $158,836	1,276 Added 22.85%	6,860 $769,000
Q2 2020 Jul 28, 2020	BUY	$57.09 - $79.27 $113,266 - $157,271	1,984 Added 55.11%	5,584 $436,000
Q1 2020 May 06, 2020	BUY	$48.11 - $82.22 $33,388 - $57,060	694 Added 23.88%	3,600 $211,000
Q3 2019 Oct 18, 2019	BUY	$72.9 - $101.41 $37,980 - $52,834	521 Added 21.84%	2,906 $214,000
Q1 2019 Apr 29, 2019	SELL	$48.7 - $86.6 $25,421 - $45,205	-522 Reduced 17.96%	2,385 $191,000
Q2 2018 Aug 06, 2018	BUY	$60.96 - $101.18 $29,992 - $49,780	492 Added 20.37%	2,907 $185,000
Q1 2018 May 03, 2018	BUY	$73.28 - $102.95 $40,230 - $56,519	549 Added 29.42%	2,415 $221,000
Q4 2017 Jan 31, 2018	BUY	$62.91 - $88.32 $42,778 - $60,057	680 Added 57.34%	1,866 $141,000
Q3 2017 Nov 08, 2017	BUY	$42.37 - $69.67 $50,250 - $82,628	1,186	1,186 $83,000

Others Institutions Holding BPMC

# of Institutions

351

Shares Held

60.3M

Call Options Held

2.25M

Put Options Held

1.18M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.4B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account

Zurcher Kantonalbank (Zurich Cantonalbank) Blueprint Medicines Corp Transaction History